Faster, Cost-Effective Alternative to Generic Bioequivalence

Discover SmartTrack to advance the development of OINDPs. Streamline inhalation and nasal therapies with optimized particle size distribution.

Mixed Kinetic Model of Inhaled Corticosteroid Dissolution

Explore the dissolution kinetics of inhaled pharmaceuticals in dry powder inhalers (DPI) and pressurized metered dose inhalers (pMDI).

Automated Classification of DPI Agglomerate Particles

Explore automated classification of dry powder inhaler particles using Cluster Analysis and Morphologically Directed Raman Spectroscopy.

Challenges in OINDPs Achieving Q3 Equivalence

Nanopharm review the bioequivalence challenges for OINDPs by achieving Q3 structural equivalence.

Structural Dynamics of Fluticasone Propionate Processing

Nanopharm explores the effect of secondary processing on the structural relaxation dynamics of Fluticasone Propionate.

Secondary Processing’s Effect on Fluticasone Dynamics

Explore the effect of secondary processing on the structural relaxation dynamics of Fluticasone Propionate in DPIs.

Cohesive-Adhesive Balances in DPIs

Explore Dry Powder Inhaler development through Atomic Force Microscopy. Uncover Cohesive-Adhesive balances in OINDP for effective inhaler formulations.